US BANCORP \DE\ - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$41,311
-28.0%
2,558
+85.1%
0.00%
Q2 2023$57,354
-36.6%
1,382
-8.2%
0.00%
Q1 2023$90,510
-9.7%
1,505
+10.2%
0.00%
Q4 2022$100,195
-49.1%
1,366
-47.1%
0.00%
Q3 2022$197,000
+6.5%
2,584
-2.6%
0.00%
Q2 2022$185,000
-21.9%
2,654
-7.1%
0.00%
Q1 2022$237,000
+31.7%
2,857
+18.9%
0.00%
Q4 2021$180,000
-30.8%
2,403
+7.4%
0.00%
Q3 2021$260,000
-64.6%
2,237
-32.4%
0.00%
-100.0%
Q2 2021$734,000
+92.7%
3,308
+14.9%
0.00%0.0%
Q1 2021$381,000
-20.0%
2,878
+4.4%
0.00%0.0%
Q4 2020$476,000
-53.8%
2,756
-70.2%
0.00%
-66.7%
Q3 2020$1,030,000
+87.6%
9,252
-0.2%
0.00%
+200.0%
Q2 2020$549,000
-20.7%
9,266
-9.8%
0.00%
-50.0%
Q1 2020$692,000
-22.6%
10,274
-3.2%
0.00%0.0%
Q4 2019$894,000
+9.6%
10,611
-2.7%
0.00%0.0%
Q3 2019$816,000
-0.7%
10,911
-16.1%
0.00%0.0%
Q2 2019$822,000
+26.5%
13,000
-3.7%
0.00%0.0%
Q1 2019$650,000
+43.8%
13,5000.0%0.00%
+100.0%
Q4 2018$452,000
-33.6%
13,500
+3.8%
0.00%
-50.0%
Q3 2018$681,000
+67.3%
13,0000.0%0.00%
+100.0%
Q2 2018$407,000
+43.8%
13,0000.0%0.00%0.0%
Q1 2018$283,000
+7.6%
13,0000.0%0.00%0.0%
Q4 2017$263,000
+1.9%
13,0000.0%0.00%0.0%
Q3 2017$258,000
+49.1%
13,000
+30.0%
0.00%0.0%
Q2 2017$173,000
+113.6%
10,0000.0%0.00%
Q1 2017$81,000
+2.5%
10,0000.0%0.00%
Q4 2016$79,00010,0000.00%
Other shareholders
NOVOCURE LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders